Trial Profile
A Randomized, Prospective, Multicenter, Open-label Study to Evaluate the Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir in HBeAg-positive Chronic Hepatitis B Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Tenofovir (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms TETRA
- 08 May 2012 New trial record